Alessandro Mengozzi
Studying at Unipi: Courses, enrolment and services for every stage of your academic journey, from orientation to post-graduate opportunities
Services and opportunities to support students through their university journey within a campus that is connected to the city
Through our research we expand the frontier of knowledge and prepare people ready to contribute to the future of society
We collaborate with industry and society to expand the frontiers of knowledge and drive cultural, social, and economic impact nationwide
We promote the dissemination of knowledge and support social transformation, contributing to the progress of both the community and the region
The identity of Unipi: its history, its guiding values and its vision for the future, between tradition, innovation and community commitment
Unit: Dipartimento di Medicina Clinica e Sperimentale
Scientific-disciplinary sector: Medicina Interna MEDS-05/A
Location: Ospedale Cisanello, Edificio 30, 3° piano, Stanza 54
Time: Venerdì mattina, previo appuntamento via email
Alessandro Mengozzi, MD, PhD, is an RTDA (Italian Junior assistant professor) in the Department of Clinical and Experimental Medicine at the University of Pisa. His research aims at exploring the early mechanisms of cardiometabolic damage with a translational approach, focusing on vascular function, inter-organ cross-talk (between vascular and adipose tissue), and circulating biomarkers of early cardiometabolic impairment (mitochondrial function and non-coding RNAs). He leverage on a multidisciplinary group at Microcirculation Lab, UniPi, and he has established strong collaborations within the University of Pisa and with leading research groups across Italy and Europe.
The results of dr. Mengozzi’s research have been published in major international journals, presented at national and international cardiometabolic meetings, and have received awards from the Italian Society of Arterial Hypertension (SIIA), the Italian Society of Diabetology (SID), the European Society of Cardiology (ESC), and the European Association for the Study of Diabetes (EASD).